How can we best optimize pharmacotherapy for patients with Type 2 diabetes? What are the main treatment barriers to keep in mind, and what are the most common comorbidities that we might be able to treat concurrently with diabetes therapy? Dr. Susan Cornell, assistant professor of pharmacy practice at Midwestern University Chicago College of Pharmacy, takes a closer look at these questions, and also shares strategies to directly collaborate with diabetic patients in managing the consequences of their disease. Dr. Charles Turck hosts.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Current Trends and Treatment Goals for Diabetes
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Overview
How can we best optimize pharmacotherapy for patients with Type 2 diabetes? What are the main treatment barriers to keep in mind, and what are the most common comorbidities that we might be able to treat concurrently with diabetes therapy? Dr. Susan Cornell, assistant professor of pharmacy practice at Midwestern University Chicago College of Pharmacy, takes a closer look at these questions, and also shares strategies to directly collaborate with diabetic patients in managing the consequences of their disease. Dr. Charles Turck hosts.
Facebook Comments